Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.


The STERRAD VELOCITY System offers 15-minute time to results, the fastest biological indicator on the market.* It’s also the only rapid read process challenge device validated for STERRAD Systems that meets AAMI recommended guidelines for verifying sterility assurance. •

*Fastest Biological Indicator/Process Challenge Device currently marketed for STERRAD Sterilization Systems. 15 or 30 minutes to result dependent on the software version on the STERRAD VELOCITY® Reader. 15 minutes to result for SW version 1139260410 or greater; 30 minutes to result for SW version 1139260317 or below.



Submit a Comment

Your email address will not be published. Required fields are marked *